SML3537
CK156
≥98% (HPLC)
别名:
N-tert-Butyl-7,10-dioxa-13,17,18,21-tetraazatetracyclo[12.5.2.1²,⁶.0¹⁷,²⁰]docosa-1(20),2,4,6(22),14(21),15,18-heptaene-5-carboxamide
InChI
1S/C21H25N5O3/c1-21(2,3)25-20(27)15-5-4-14-12-17(15)29-11-10-28-9-7-22-18-6-8-26-19(24-18)16(14)13-23-26/h4-6,8,12-13H,7,9-11H2,1-3H3,(H,22,24)(H,25,27)
InChI key
YCFFONJEHNSECY-UHFFFAOYSA-N
SMILES string
CC(C)(C)NC(C(C=C1)=C(OCCOCCNC2=N3)C=C1C4=C3N(C=C2)N=C4)=O
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
CK156 is a potent and selective DRAK1 inhibitor (IC50 = 49 nM by cell-free radiometric assay, IC50 = 181 nM by cellular NanoBRET, KD = 21 nM by ITC, selectivity by a 468-kinase panel) with good selectivity over DRAK2 (61% inhibition at 1 μM, IC50 = 8 μM by NanoBRET).
Potent and selective DRAK1 (STK17A) inhibitor.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持